GlassScriptPhysician profile
John S Berestka
NPI 1114905072
$3,453.91
in general payments reported to CMS, 2019-2025
8 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2021: $2,801 · 2024: $156 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.51 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,950.00 | 2021 | |
| Glaukos Corporation | $750.51 | 2021-2025 | Idosetr, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Ivantis, INC | $300.38 | 2019 | |
| Allergan, INC. | $121.90 | 2021 | |
| The Cameron-Ehlen Group, INC. | $104.46 | 2021 | |
| Rxsight INC | $91.40 | 2021-2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $76.16 | 2019 | |
| W. L. Gore & Associates, INC. | $59.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Berestka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.